Your browser doesn't support javascript.
loading
Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate Cancer.
Repka, Michael C; Creswell, Michael; Lischalk, Jonathan W; Carrasquilla, Michael; Forsthoefel, Matthew; Lee, Jacqueline; Lei, Siyuan; Aghdam, Nima; Kataria, Shaan; Obayomi-Davies, Olusola; Collins, Brian T; Suy, Simeng; Hankins, Ryan A; Collins, Sean P.
Afiliação
  • Repka MC; Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, NC, United States.
  • Creswell M; Georgetown University School of Medicine, Washington, DC, United States.
  • Lischalk JW; Department of Radiation Oncology at New York University (NYU) Long Island School of Medicine, Perlmutter Cancer Center at NYCyberKnife, New York, NY, United States.
  • Carrasquilla M; Department of Radiation Medicine, MedStar Georgetown University Hospital, Washington, DC, United States.
  • Forsthoefel M; Department of Radiation Oncology, Radiotherapy Centers of Kentuckiana, Louisville, KY, United States.
  • Lee J; Georgetown University School of Medicine, Washington, DC, United States.
  • Lei S; Department of Radiation Medicine, MedStar Georgetown University Hospital, Washington, DC, United States.
  • Aghdam N; Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA, United States.
  • Kataria S; Department of Radiation Oncology, Arlington & Reston Radiation Oncology, Arlington, VA, United States.
  • Obayomi-Davies O; Department of Radiation Oncology, Wellstar Kennestone Hospital, Marietta, GA, United States.
  • Collins BT; Department of Radiation Medicine, MedStar Georgetown University Hospital, Washington, DC, United States.
  • Suy S; Department of Radiation Medicine, MedStar Georgetown University Hospital, Washington, DC, United States.
  • Hankins RA; Department of Urology, MedStar Georgetown University Hospital, Washington, DC, United States.
  • Collins SP; Department of Radiation Medicine, MedStar Georgetown University Hospital, Washington, DC, United States.
Front Oncol ; 12: 860848, 2022.
Article em En | MEDLINE | ID: mdl-35433457

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça